DCGI approves India’s 1st homemade Pneumonia vaccine

India’s first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has received the approval from Drug Controller General of India (DCGI). It will be utilized for active immunization against invasive disease and pneumonia caused by “Streptococcus pneumonia” among infants.

Boost your Banking Awareness Knowledge with Adda247 Live Batch: TARGET GA BATCH | Banking Awareness Batch for SBI, RRB, RBI and IBPS Exams

Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has been developed by Serum Institute of India Pvt Ltd, Pune. It is India’s first indigenously developed vaccine in the field of pneumonia. With the DCGI’s approval, Serum Institute of India has been granted permission to manufacture the vaccine domestically.

Find More National News Here